Squarepoint
IMUX icon

Squarepoint’s Immunic IMUX Stock Holding History

Squarepoint’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,288
Closed -$188K – 4589
2025
Q4 		$188K Buy
35,288
+8,131
+30% +$59.6K ﹤0.01% 3893
2025
Q3 		$239K Buy
+27,157
New +$240K ﹤0.01% 3822
2024
Q3 		– Sell
-2,205
Closed -$24.5K – 4371
2024
Q2 		$24.5K Sell
2,205
-927
-30% -$11.5K ﹤0.01% 3953
2024
Q1 		$41.3K Buy
+3,132
New +$40.7K ﹤0.01% 3888
2021
Q1 		– Sell
-4,164
Closed -$637K – 3341
2020
Q4 		$637K Buy
4,164
+1,745
+72% +$313K ﹤0.01% 1625
2020
Q3 		$449K Buy
+2,419
New +$396K 0.01% 1516

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Squarepoint's IMUX Position: Q1 2026 in Review

Squarepoint sold out of Immunic (IMUX) in Q1 2026, closing a stake of 35,288 shares — an estimated $188K sold.

Squarepoint first reported a position in IMUX in Q3 2020 and held it in 6 quarters. The position peaked at $637K in Q4 2020. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Squarepoint reported no remaining Immunic position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 35,288 Immunic shares in Q1 2026, an estimated $188K.
  • Squarepoint first reported a position in Immunic in Q3 2020 and held it in 6 quarters.
  • Squarepoint's Immunic position peaked at $637K in Q4 2020.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.